SMETANA, Karel and Michal MASAŘÍK. Advances in Cancer Metabolism and Tumour Microenvironment. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. Basel: MDPI, 2022, vol. 23, No 8, p. 1-4. ISSN 1422-0067. Available from: https://dx.doi.org/10.3390/ijms23084071.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Advances in Cancer Metabolism and Tumour Microenvironment
Authors SMETANA, Karel (203 Czech Republic) and Michal MASAŘÍK (203 Czech Republic, guarantor, belonging to the institution).
Edition INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, Basel, MDPI, 2022, 1422-0067.
Other information
Original language English
Type of outcome Article in a journal (not reviewed)
Field of Study 10608 Biochemistry and molecular biology
Country of publisher Switzerland
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 5.600
RIV identification code RIV/00216224:14110/22:00129050
Organization unit Faculty of Medicine
Doi http://dx.doi.org/10.3390/ijms23084071
UT WoS 000785100300001
Keywords in English Cancer Metabolism; Tumour Microenvironment
Tags rivok
Tags International impact
Changed by Changed by: Mgr. Tereza Miškechová, učo 341652. Changed: 9/1/2023 14:18.
Abstract
Cancer represents an extremely complicated ecosystem where cancer cells communicate with non-cancer cells present in the tumour niche through intercellular contacts, paracrine production of bioactive factors and extracellular vesicles, such as exosomes. The non-cancer cells that participate in the control of biological properties of the malignant disease include cancer-associated fibroblasts (CAFs), tumour-associated macrophages, granulocytes, NK cells and subsets of lymphocytes . Differences in the metabolism of cancer cells were established many years ago, and the relationship between the tumour microenvironment (TME) and the metabolism was shown. Distinguished scientists have prepared highly instructive articles on this topic with the aim of gaining a deeper insight into the role of the microenvironment and the differences in the cancer cell metabolism to refine the diagnostics and propose new strategies for anticancer therapy. Tumour cells share the common ability to obtain necessary nutrients from a relatively poor environment and use them flexibly to maintain their viability and build new biomass. Bioenergetically demanding processes accompanying malignant transformation, such as rapid proliferation and the ability to migrate, require increased production of adenosine triphosphate (ATP), nucleic acids, proteins and lipids. The changes in intracellular and extracellular metabolites that accompany the metabolic reprogramming associated with tumour growth subsequently have a profound effect on gene expression, cellular differentiation and the tumour microenvironment.
Links
GA21-06873S, research and development projectName: Metabolická symbióza mezi nádorovými buňkami a fibroblasty asociovaných s nádorem u nádorů v oblasti hlavy a krku
Investor: Czech Science Foundation
NU21-03-00223, research and development projectName: Vliv metabolického reprogramování fibroblastů asociovaných s nádorem na prognózu pacientů s nádory hlavy a krku
Investor: Ministry of Health of the CR, Subprogram 1 - standard
PrintDisplayed: 29/7/2024 22:00